Impaired NAD+ Metabolism in Neuronal Dysfunction in Critical Conditions

Impaired NAD+ Metabolism in Neuronal Dysfunction in Critical Conditions

The present views of the pathogenesis of neuronal dysfunction in critical conditions are analyzed, by taking into account of impairments of cellular NAD+ metabolism, the activity of NAD+-converting enzymes, including ADP-ribosyl cyclase/CD38, the possibilities of developing new neuroprotective strat...

Full description

Bibliographic Details
Main Authors:	A. V Salmina, A. A. Fursov, S. V Mikhutkina, S. V. Shakhmayeva, N. S. Mantorova
Format:	Article
Language:	Russian
Published:	Russian Academy of Medical Sciences 2008-02-01
Series:	Obŝaâ Reanimatologiâ
Online Access:	https://www.reanimatology.com/rmt/article/view/829

Similar Items

Development of Systemic Inflammatory Reaction after Aortocoronary Bypass Surgery: New Aspects
by: V. V. Moroz, et al.
Published: (2008-12-01)

Pathogenesis of a Systemic Inflammatory Reaction: New Aspects
by: AA. Fursov, et al.
Published: (2008-04-01)

Impaired Iron Metabolism in the Pathogenesis of Critical Conditions (an Experimental Study)
by: Yu. P. Orlov, et al.
Published: (2011-10-01)

Prevention of Postischemic Neurological Deficit by Modulating the Cerebral Cell Expression of ADP-Ribosyl Cyclase (Experimental Study)
by: A. A. Fursov, et al.
Published: (2007-12-01)

Role of Nitric Oxide in Neuronal Damages in Critical Conditions
by: A. V. Kiseleva, et al.
Published: (2009-10-01)

Metabolic Desynchronization in Critical Conditions: Experimental Study
by: G. V. Livanov, et al.
Published: (2006-02-01)

Inhibition of the NAD salvage pathway in schistosomes impairs metabolism, reproduction, and parasite survival.
by: Michael D Schultz, et al.
Published: (2020-05-01)

Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication
by: Knut H Lauritzen, et al.
Published: (2021-08-01)

Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays
by: Vasily A. Aleshin, et al.
Published: (2015-08-01)

NAD+ Metabolism, Metabolic Stress, and Infection
by: Benjamin Groth, et al.
Published: (2021-05-01)

KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts
by: Kang-Sik Seo, et al.
Published: (2018-07-01)

Impact of Iron Metabolic Disturbances on Hemostasis in Critical Conditions
by: Yu. P. Orlov, et al.
Published: (2007-04-01)

Integration of Metabolism in Man and His Microbiome in Critical Conditions
by: N. V. Beloborodova
Published: (2012-08-01)

NAD Metabolism in Cancer Therapeutics
by: Keisuke Yaku, et al.
Published: (2018-12-01)

Some Aspects of NAD Metabolism
by: Lindsey, G. G.
Published: (1973)

Discretization Matrix Condition Estimate in Finite Volume Method
by: E. V. Avdeev, et al.
Published: (2014-01-01)

Implications of altered NAD metabolism in metabolic disorders
by: Keisuke Okabe, et al.
Published: (2019-05-01)

Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons
by: Nady Braidy, et al.
Published: (2011-01-01)

Effects of Kynurenine Pathway Inhibition on NAD+ Metabolism and Cell Viability in Human Primary Astrocytes and Neurons
by: Nady Braidy, et al.
Published: (2011-05-01)

The Impair Iron Metabolism in Acute Pancreatitis
by: Yu. P. Orlov, et al.
Published: (2010-10-01)

Pathogenetic Role of Cholesterol and Triglyceride Metabolic Disturbances in the Development of Critical Conditions
by: S. A. Perepelitsa, et al.
Published: (2015-10-01)

Editorial: NAD Metabolism and Signaling in Plants
by: Alisdair Fernie, et al.
Published: (2020-02-01)

Studies of the NAD metabolism of Haemophilus influenzae
by: Kahn, David W.
Published: (2015)

Structural modeling of NAD+ binding modes to PARP-1
by: N. V. Ivanisenko, et al.
Published: (2017-02-01)

Treatment of arterial hypertension in metabolic syndrome in men with erectile dysfunction
by: S. V. Nedogoda, et al.
Published: (2013-12-01)

Changes in NAD/ADP-ribose metabolism in rectal cancer
by: L. Yalcintepe, et al.
Published: (2005-03-01)

Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment
by: Lan Fan, et al.
Published: (2020-11-01)

Ozone Exposure Induces Metabolic Disorders and NAD+ Depletion Through PARP1 Activation in Spinal Cord Neurons
by: Shulin Ma, et al.
Published: (2020-12-01)

Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?
by: Marwa Elamin, et al.
Published: (2017-11-01)

Noliprel and endothelial dysfunction correction in metabolic syndrome patients
by: V. V. Trusov, et al.
Published: (2005-12-01)

Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration
by: Ravirajsinh N. Jadeja, et al.
Published: (2020-01-01)

Role of NAD+ in regulating cellular and metabolic signaling pathways
by: Sara Amjad, et al.
Published: (2021-07-01)

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
by: Nicola Curtin, et al.
Published: (2020-11-01)

NAD+ metabolism, stemness, the immune response, and cancer
by: Lola E. Navas, et al.
Published: (2021-01-01)

Development of L1210 mutants in NAD metabolism
by: Sujareerat, Charin
Published: (1989)

Metabolism and Congenital Malformations - NAD's Effects on Development
by: Vander Heiden, Matthew G.
Published: (2018)

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
Published: (2023)

Targeting NAD+ metabolism in the human malaria parasite Plasmodium falciparum.
by: Jessica K O'Hara, et al.
Published: (2014-01-01)

RATIONALE FOR PREVENTION OF CARDIO-CEREBRAL COMPLICATIONS IN THE METABOLIC SYNDROME BASED ON MATHEMATICAL FORECASTING TECHNIQUES
by: S. V. Chernavskii, et al.
Published: (2014-07-01)

RATIONALE FOR PREVENTION OF CARDIO-CEREBRAL COMPLICATIONS IN THE METABOLIC SYNDROME BASED ON MATHEMATICAL FORECASTING TECHNIQUES
by: S. V. Chernavskii, et al.
Published: (2014-07-01)